Cesca: ThermoGenesis Holdings To Announce Financial Results For The Third Quarter Ended September 30, 2019 And Provide A Corporate Strategic Update
Conference Call to be Held on November 12, 2019
Read full article »
Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases.
Read more